Article Text

PDF
Cardiovascular highlights from non-cardiology journals
  1. James M McCabe
  1. Division of Cardiology, University of Washington, Seattle, Washington, USA
  1. Correspondence to Dr James M McCabe, Division of Cardiology, University of Washington, Seattle, WA 98195, USA; jmmccabe{at}cardiology.washington.edu

Statistics from Altmetric.com

Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study

Use of transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) has grown rapidly over the last decade and the technology has correspondingly matured. Nevertheless, recent data suggest that subclinical thrombosis may form on some leaflets of the TAVR prostheses following implant. The frequency, implications, and required treatment of this process are largely unknown, as is the relevance to surgical aortic valve replacement (SAVR). Two single centre registries, The Assessment of Transcatheter and Surgical Aortic Bioprosthetic Valve Thrombosis and its Treatment with Anticoagulation (RESOLVE) and the Subclinical Aortic Valve Bioprosthesis Thrombosis Assessed with Four-Dimensional Computed Tomography (SAVORY), collectively enrolled 890 non-consecutive patients who underwent 4D volume-rendered CT at various intervals following TAVR (752 patients) or SAVR (138 patients) between 2014 and 2017 with the intent to explore the prevalence of subclinical leaflet thrombosis. Relative to SAVR prostheses, a higher percentage of TAVR patients had thrombus detected (12% vs …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.